Navigation Links
Abbott to Present Data on Market-Leading XIENCE V® and Promising Vascular Pipeline at TCT 2010
Date:9/16/2010

including important safety information, is available online at www.xiencev.com or www.abbottvascular.com/en_US/content/document/eIFU_XienceV.pdf.

About Abbott VascularAbbott Vascular is a global leader in cardiac and vascular care with market-leading products and an industry-leading pipeline. Abbott Vascular offers a comprehensive cardiac and vascular devices portfolio, including products for coronary artery disease, vessel closure, endovascular disease, and structural heart disease.

About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.  

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.


'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Sept. 4, 2015  Pharmaceutical companies today rely ... Field-Based Medical Specialists (FBMS) to build and strengthen ... thought leaders in critical therapeutic areas. ... teams, companies are expanding the critical MSL function ... with corporate objectives and to achieve regional consistency, ...
(Date:9/4/2015)... Texas , Sept. 4, 2015  Luminex Corporation ... present at the Morgan Stanley Global Healthcare Conference to ... Grand Hyatt Hotel in New York City ... at 11:40 a.m. Eastern time on Friday, September 18, ... accessed at Luminex Corporation,s website at http://www.luminexcorp.com . ...
(Date:9/4/2015)... SOUTH PLAINFIELD, N.J. , Sept. 4, 2015 ... is pleased to announce five recipients of its ... to Realize Innovation, Vision and Empowerment), designed to ... the Duchenne muscular dystrophy (DMD) community. The announcement ... for the international World Duchenne Awareness Day on ...
Breaking Medicine Technology:New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4
... March 14, 2012  MAKScientific, LLC, a privately held company ... pathways, today announced that it has entered into an ... (NASDAQ: BIIB ) to develop and commercialize ... and other neurodegenerative diseases. Under the agreement, ...
... March 14, 2012  Apricus Biosciences, Inc. Chief Executive Officer, ... http://www.apricusbio.com ) said in an interview with Charles Sample ... from a clinical development company to an income-generating, hybrid ... at: http://www.ceonews.tv/apri Damaj cited the ...
Cached Medicine Technology:Apricus Biosciences, Inc. (APRI) Transforms From Development Company to Income Generating! 2Apricus Biosciences, Inc. (APRI) Transforms From Development Company to Income Generating! 3Apricus Biosciences, Inc. (APRI) Transforms From Development Company to Income Generating! 4
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... out to benefit Core Compassion Project. Core Compassion Project is a non-profit ... program to reduce the side effects of cancer treatments and recover their mobility, ...
(Date:9/4/2015)... ... September 04, 2015 , ... Mike Day, a former Navy SEAL who was ... Ironman World Championships in Kona on October 10th. , Mike is running the race ... through combat and the cutting-edge treatments that restore their quality of life. ...
(Date:9/4/2015)... ... 04, 2015 , ... Having access to a doctor can sometimes be a ... of unnecessary emergency room visits which affects hospitals’ abilities to provide quality service to ... a solution to alleviate this problem has recently presented itself, the new telemedicine platform ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... are prophetic details involving the Pope’s upcoming trip to the United States. , Yisrayl lays ... his role with the Vatican and society is. Yisrayl also provides the meaning of his ...
(Date:9/3/2015)... Angeles, CA (PRWEB) , ... September 03, 2015 , ... ... patients as to the best practices when preparing for a bariatric procedure, some patients ... a procedure. Apart from the basic instructions typical for many types of surgery that ...
Breaking Medicine News(10 mins):Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:Dr. Feiz and Associates Answer August's ‘Patient Submitted Question of the Month’: “How Can I Prepare for Weight Loss Surgery” 2
... UC Irvine neuroscientists have received $2 million to ... findings could lead to clinical research and treatment of ... UCI scientists hope to gain a greater understanding of ... the auditory cortex. , "We still don,t know how ...
... a new imprint devoted to the relationships between men and ... HOME. AFRAID TO GO HOME, a 420 page paperback, is ... advantage of at work by the Good Ol, Boys, and ... herself and her children from at home."One of the reasons ...
... to Consumer Reports Health News for health and ... issues pertaining to the efficacy and safety of ... health, diet and nutrition, food safety, and fitness. ... the effectiveness and affordability of prescription drugs, and ...
... Abnormal Heart RhythmsAUSTIN, Texas, March 3 On ... Institute at St. David,s Medical Center became the ... long-awaited NaviStar(R) RMT ThermoCool(R) Catheter to treat abnormal ... received FDA approval on Friday, Feb. 27, 2009.The ...
... effectiveness of the only tuberculosis vaccine approved for humans ... pre-clinical test, report scientists at The University of Texas ... ,s Advance Online Publication March 1. Their findings resulted ... the National Institutes of Health (NIH). , Bacille ...
... to zero, saves nearly $2 millionCARY, Ill., March 3 ... or immobilized are at a higher risk for the ... conditions that can significantly reduce quality of life. Establishment ... of heel protectors resulted in 100 percent prevention of ...
Cached Medicine News:Health News:AFRAID TO GO HOME, A Novel About Violence Against Women, Released By Tristan/Isolde Publishing 2Health News:Consumer Reports Health News 2Health News:Consumer Reports Health News 3Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval 2Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval 3Health News:TB breakthrough could lead to stronger vaccine 2Health News:TB breakthrough could lead to stronger vaccine 3Health News:Clinical Intervention Eliminates Heel Ulcer Incidents in ICU 2
A comprehensive CPT surgical, radiological and anesthesia coding reference....
PDA-version of the standard reference work in rheumatology....
PDA application providing a complete guide for the diagnosis and management of electrolyte disorders....
Information on diagnosis and management of 500 common or important medical and surgical disorders....
Medicine Products: